MedPath

To study the effect of a drug used during caesarean section, on tightening of the uterus.

Not Applicable
Completed
Conditions
Health Condition 1: O82- Encounter for cesarean delivery without indication
Registration Number
CTRI/2021/03/031925
Lead Sponsor
Jss Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
90
Inclusion Criteria

All women between 18 ââ?¬â?? 35 years of age, at gestational age >34 weeks undergoing elective lower segment caesarean section at Department of OBG, JSS Hospital, Mysore

Exclusion Criteria

Severe pre eclampsia or eclampsia

Antepartum haemorrhage

Maternal or fetal compromise

Over distended uterus such as polyhydramnios or multiple pregnancy

Severe anaemia

Cardiac disease complicating pregnancy

Hematologic disorders leading to low platelet count

APLA or SLE complicating pregnancy

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
To determine the best time of oxytocin administration during Lower Segment Caesarean Section.Timepoint: 1. immediately after skin incision <br/ ><br>2. immediately after uterine incision <br/ ><br>3. immediately after baby extraction
Secondary Outcome Measures
NameTimeMethod
1)To determine the need for additional utero tonics, and record any clinically significant atonic post-partum haemorrhage following administration of oxytocin at the above times. <br/ ><br> <br/ ><br>2)To determine any changes in hemodynamic parameters following administration of oxytocin at the above times. <br/ ><br>Timepoint: intraoperative at various intervals
© Copyright 2025. All Rights Reserved by MedPath